Last updated on November 2017

A randomized, double-blind study to compare the cardiovascular safety of allopurinol and febuxostat


Brief description of study

A randomized, double-blind study to compare the cardiovascular safety of allopurinol and febuxostat

Detailed Study Description

A nine year study comparing the cardiovascular safety of allopurinol and febuxostat (Uloric) in patients with gout and cardiovascular comorbidities

Clinical Study Identifier: TX7610

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Theresa Bass-Goldman

The Center for Rheumatology and Bone Research
Wheaton, MD USA
  Connect »